tyme technologies stock forum
TYME stock quote history news and other vital information to help you with your stock trading and investing. TYME stock discussion in Yahoo Finances forum.
Revisiting Tyme Technologies Nasdaq Tyme Seeking Alpha
Find the latest Tyme Technologies Inc.
. Tyme Technologies Inc a biotechnology company develops cancer metabolism-based therapies CMBTs in the United States. Entering text into the input field will update the search result below. TYME Stock Message Board for Investors.
888-992-3836 NewsWire Home Login. Ad 1000 Strong Buy Stocks that Double the SP. Is a biotechnology company.
Announces Exploration of Strategic Options. Tyme Technologies TYME stock price charts trades the USs most popular discussion forums. Stock Price News and Company Updates.
And has now gained 3 days in a row. These institutions hold a total of 16151006 shares. BEDMINSTER NJ March 29 2022 GLOBE NEWSWIRE -- TYME Technologies Inc.
The Tyme Technologies Inc stock price gained 1056 on the last trading day Thursday 17th Mar 2022 rising from 029 to 033. Today we look at Tyme Technologies whose stock rose nearly 20 in trading on Wednesday. Tyme Technologies NASDAQTYME and Theratechnologies NASDAQTHTX are both small-cap medical companies but which is the better stockWe will contrast the two businesses based on the strength of their analyst recommendations community ranking valuation risk profitability institutional ownership media sentiment earnings and dividends.
Free forex prices toplists indices and lots more. The Company is focused on developing cancer metabolism-based therapies CMBTs for a range of solid tumors and hematologic cancers. Free forex prices toplists indices and lots more.
TYME 035 001 155 Pre-Market 000 000 12089. Since then TYME stock has decreased by 701 and is now trading at 03138. The Companys lead clinical CMBT compound SM-88 is an oral investigational modified tyrosine derivative that is hypothesized to interrupt the metabolic.
The company also offers TYME-19 an oral. The reporting person undertakes to provide to Tyme Technologies Inc any security holder of Tyme Technologies Inc or the staff of the Securities and Exchange Commission upon request full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Tyme Technologies Inc NASDAQ Updated Mar 24 2022 942 AM.
Friday June 11 2021 Futures UpDown Last Dow 7500 022 34429 SP 500 425 011 4233 Nasdaq 1350 009 13963 Stock futures are looking higher trying to build off yesterdays gains as the SP 500 Index posted its first closing high in over a month and as the Nasdaq Composite outperformed rising over 075 as the yield on the benchmark 10-year. Seeking Alpha - Go to Homepage. Medical - Drugs Total Posts.
Institutional Ownership and Shareholders. Its lead candidate is the SM-88 a CMBT that is in a Phase IIIII clinical trial to treat across 15 types of cancer including pancreatic lung breast prostate sarcoma and lymphoma. Free forex prices toplists indices and lots more.
Announces SM-88 Poster at the American Association for Cancer Research AACR Annual Meeting 2022. Tyme Technologies Inc TYME USD00001 Hargreaves Lansdown 2182022 TYME Technologies Inc. Tyme Technologies stock was trading at 105 on March 11th 2020 when Coronavirus reached pandemic status according to the World Health Organization WHO.
Tyme Technologies Inc USTYME has 94 institutional owners and shareholders that have filed 13DG or 13F forms with the Securities Exchange Commission SEC. Message Board Total Posts. TYME Tyme Technologies Inc Stock Price and Discussion Stocktwits.
Its lead candidate is the SM-88 a CMBT that is in a Phase IIIII clinical trial to treat across 15 types of cancer including pancreatic lung breast prostate sarcoma and lymphoma. Tyme Technologies Inc Stock Symbol. Stock technical analysis with dynamic chart and Delayed Quote Nasdaq.
View which stocks have been most impacted by COVID-19. TYME the Company or TYME an emerging biotechnology company developing cancer metabolism-based therapies CMBTs today announced that its Board of Directors has decided to explore potential. Find the latest Tyme Technologies Inc.
Strong day for Tyme Technologies Inc stock price on Thursday rising 1056 to 033Updated on Mar 17 2022 Buy candidate since 2022-03-17 PDF. Tyme Technologies TYME stock price charts trades the USs most popular discussion forums. Tyme Technologies TYME stock price charts trades the USs most popular discussion forums.
Share your opinion and gain insight from other stock traders and investors. Tyme Technologies Inc a biotechnology company develops cancer metabolism-based therapies CMBTs in the United States. Largest shareholders include Vanguard Group Inc VTSMX - Vanguard Total Stock Market Index.
Revisiting Tyme Technologies Nasdaq Tyme Seeking Alpha
Tyme Technologies Inc Tyme Stock Forum Discussion Yahoo Finance
Tyme Tyme Technologies Inc Stock Discussion Stock Forum Stock Price And Company Information Echofin
Tyme Technologies Inc Tyme Stock Message Board Investorshub
Tyme Technologies Recent Sell Off Provides Opportunity To Buy At A Discount Nasdaq Tyme Seeking Alpha
Tyme Technologies Inc Tyme Stock Forums Investing Com
Tyme Technologies Inc Tyme Stock Message Board Investorshub
Tyme Technologies Inc Tyme Stock Message Board Investorshub
Revisiting Tyme Technologies Nasdaq Tyme Seeking Alpha
N Csr 1 Filing788 Htm Primary Document United States Securities And Exchange Commission Washington D C 20549 Form N Csr Certified Shareholder Report Of Registered Management Investment Companies
Tyme Technologies Inc Tyme Stock Message Board Investorshub
Tyme Technologies Inc Tyme Stock Message Board Investorshub
Tyme Technologies Inc Tyme Stock Message Board Investorshub
Tyme Technologies Recent Sell Off Provides Opportunity To Buy At A Discount Nasdaq Tyme Seeking Alpha
Tyme Technologies Inc Tyme Stock Message Board Investorshub
Tyme Technologies Inc Tyme Stock Price And Discussion March 2022 Wallmine
Tyme Technologies Inc Tyme Stock Forums Investing Com
Tyme Technologies My Bamboo Speculation In A Potential Leader In Cancer Metabolism Based Therapies Nasdaq Tyme Seeking Alpha